p16INK4A (CDKN2A) Rabbit Polyclonal Antibody

CAT#: TA326118

Rabbit polyclonal p14 ARF antibody

Product Images

Western blot analysis of extracts from HeLa cells, using p14 ARF antibody (#TA326118).The lane on the right is treated with the synthesized peptide.

• 

  Western blot analysis of extracts from 293 cells (Lane 2), using p14 ARF Antibody. The lane on the left is treated with synthesized peptide.

• 

  Immunohistochemical analysis of paraffin-embedded human placenta tissue using p14 ARF antibody (#TA326118).The picture on the right is treated with the synthesized peptide.

• 

  Immunofluorescence analysis of HeLa cells, using p14 ARF antibody (#TA326118).The picture on the right is treated with the synthesized peptide.

Specifications

Product Data

• Applications: IF, IHC, WB
• Recommended Dilution: WB: 1:500~1:3000 IHC: 1:50~1:100IF: 1:100~1:500 ELISA: 1:5000
• Reactivities: Human
• Host: Rabbit
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: The antiserum was produced against synthesized peptide derived from human p14 ARF antibody.
• Formulation: Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
• Concentration: lot specific
• Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: cyclin-dependent kinase inhibitor 2A
• Database Link:
  NP_000068
  Entrez Gene 1029 Human
  UniProt ID Q8N726
• Synonyms: ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4

Reference Data

• Protein Families: Druggable Genome
• Protein Pathways: Bladder cancer, Cell cycle, Chronic myeloid leukemia, Glioma, Melanoma, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Pathways in cancer